{"id":"https://genegraph.clinicalgenome.org/r/449ee6c1-8829-431c-8373-0c0281784a6bv1.0","type":"EvidenceStrengthAssertion","dc:description":"Non-loss of function variation of FLNC results in the development of myofibrillar myopathy 5 presenting with a combination and isolated skeletal and cardiac features. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanism and phenotypic variability. Loss of function variation causes weakening of myocyte adhesion and is implicated in arrhythmogenic cardiomyopathy and dilated cardiomyopathy without musculoskeletal abnormalities (Verdonschot 2020, PMID 32112656). Conversely, the mechanism of non-loss of function variation for FLNC-induced myopathy is attributed to the aggregation of FLNC and FLNC-binding proteins in muscle and the sarcomere (Furst 2013, PMID 23109048). Therefore, we have split the molecular mechanism, curating only non-loss of function variation for the disease entity [Myopathy, myofibrillar, 5] (OMIM: 609524). Over 22 probands in 9 publications have been published (Vorgerd 2005, PMID 15929027; Kley 2007, PMID 18055494; Kley 2012, PMID 22961544; Shatunov 2009, PMID 19050726; Laun 2010, PMID 20417099; Avila-Smirnow 2012, PMID 27633507; Rold√°n-Sevilla 2019, PMID 30919686; Gaudreault 2023, PMID 36864778;; Berm√∫dez-Jim√©nez 2023, PMID 35952944). There were 16 unique heterozygous variants (12 missense, 1 in-frame deletion, 1 in-frame indel, 1 duplication, and 1 termination in the last exon). One variant (p.Trp2710Ter) was seen in 36 affected individuals across six families and represents a founder effect. Of note, FLNC has a pseudogene located 53.6kb downstream from the functional FLNC gene, and exons 46, 47, and 48 are 98% homologous in the functional and pseudogene (Odgerel 2010, PMID: 20578970). \n\nThe gene-disease relationship is also supported by expression studies, protein interaction studies, and model systems (Xie 1998, PMID 979101; Furst 2013, PMID 23109048; van der Ven 2000, PMID 11038172; Gonzalez-Morales 2017 2017, PMID 28732005; Labeit 2006, PMID 16949617; Chevessier 2015, PMID 29859533; Kiselev 2018, PMID 29859533; Ruparelia 2016, PMID 26969713; Agarwal 2012, PMID 34405687), reaching the maximum points for experimental evidence. \n\nIn summary, there is definitive evidence supporting the relationship between FLNC non-loss of function variation and autosomal dominant myofibrillar myopathy 5. This has been repeatedly demonstrated in research and clinical settings and upheld over time. This gene-disease pair was originally evaluated as definitive by the ClinGen Hypertrophic Cardiomyopathy GCEP on December 12th, 2017. As a result of this reevaluation, the classification has remained the same; however, the molecular mechanism has been split to include only non-loss of function variation approved on October 26, 2023, by the Hereditary Cardiovascular Disease GCEP.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/449ee6c1-8829-431c-8373-0c0281784a6b","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2023-10-26T01:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2024-07-10T06:45:48.589Z","role":"Publisher"}],"curationReasons":["RecurationNewEvidence"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e63b831-285c-4bba-ad3d-7de136d8765f","type":"EvidenceLine","dc:description":"Variant already scored","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e63b831-285c-4bba-ad3d-7de136d8765f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kley 2012 PMID:22961544 Transiently transferred C2 and C2C12 cells showed increased FLNC aggregation in cells expressing W2710* compared to WT ‚Äì up to 30x more  \nVorgerd 2005 PMID: 15929027 Patient muscle samples show FLNC aggregation by IMS & EM. Circular dichroism of W2710X showed improper folding compared to WT \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6e63b831-285c-4bba-ad3d-7de136d8765f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.8130G>A (p.Trp2710Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258151"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f4a7dd71-3197-4adc-bba0-52a7de584f15","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4a7dd71-3197-4adc-bba0-52a7de584f15_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/f121bb0a-ed43-48eb-930a-41367368a006","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.5864C>T (p.Ser1955Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369208918"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5a5f939e-bd07-48f6-9c64-984eaf8259ea","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a5f939e-bd07-48f6-9c64-984eaf8259ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/794ebd29-67de-4719-82ed-672fa1d3a480","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.6031G>A (p.Gly2011Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369210984"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c5c1c1d4-188e-4d7a-be47-7f63769e7dbe","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5c1c1d4-188e-4d7a-be47-7f63769e7dbe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20417099","allele":{"id":"https://genegraph.clinicalgenome.org/r/67f5f2ce-f243-4cc1-bba7-401233c9131c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.2695_2712delinsGTTTGT (p.Lys899_Val904delinsValCys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695208479"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/caa48aea-3bd2-4cad-a747-edac34901024","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/caa48aea-3bd2-4cad-a747-edac34901024_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/27cddfbc-2565-4b07-84e5-9ae5a607aa8e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.6005G>A (p.Gly2002Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369210864"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/91603bf2-d7a6-4088-a3f9-b83125c07063","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91603bf2-d7a6-4088-a3f9-b83125c07063_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/691c0cf0-2819-46ca-9572-b7edb7c2e7eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.7018C>T (p.Arg2340Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369214936"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d4a5e855-7745-4baa-947f-0be859521b14","type":"EvidenceLine","dc:description":"Functional data is theoretical ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4a5e855-7745-4baa-947f-0be859521b14_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The isoleucine residue is highly conserved & there is a large physiochemical difference with asparagine: Molecular modeling (theoretical) shows variant results in significant increase of the free energy (+2.67 ¬±0.02 kcal/mol) and the creation of 2 additional H-bonds with adjacent AAs Val1862 & Val1930 \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d4a5e855-7745-4baa-947f-0be859521b14_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36864778","allele":{"id":"https://genegraph.clinicalgenome.org/r/46bf91f7-269d-48b1-bc28-a4a1aed863e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.5810T>A (p.Ile1937Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369208548"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/26ff95f1-b763-4445-804e-86f50e83a535","type":"EvidenceLine","dc:description":"Variant already scored ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26ff95f1-b763-4445-804e-86f50e83a535_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kley 2012 PMID:22961544 Transiently transferred C2 and C2C12 cells showed increased FLNC aggregation in cells expressing W2710* compared to WT ‚Äì up to 30x more  \nVorgerd 2005 PMID: 15929027 Patient muscle samples show FLNC aggregation by IMS & EM. Circular dichroism of W2710X showed improper folding compared to WT \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/26ff95f1-b763-4445-804e-86f50e83a535_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22961544","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f85046b3-7a26-4bdb-9914-3f03d79c669b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f85046b3-7a26-4bdb-9914-3f03d79c669b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/0bc44e9c-e478-4555-8824-78f80aa5f46c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.5467A>G (p.Thr1823Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369206771"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cdb31a22-123e-4827-a504-81ffac890b9a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cdb31a22-123e-4827-a504-81ffac890b9a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/295df47b-beb3-4589-a187-61694275a19e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.7000G>A (p.Glu2334Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369214845"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/54650233-2a88-42cf-bd01-9944d31a8354","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54650233-2a88-42cf-bd01-9944d31a8354_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transiently transfected NIH3T3 cells show increased aggregation compared to WT\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/54650233-2a88-42cf-bd01-9944d31a8354_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27633507","allele":{"id":"https://genegraph.clinicalgenome.org/r/59a86e7e-7fc6-4c0d-a808-2e9ccba70f56","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.3646T>A (p.Tyr1216Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369197508"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/121c1132-816f-4dc4-8193-77df7e93f61f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22961544","rdfs:label":"7","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/121c1132-816f-4dc4-8193-77df7e93f61f","type":"Family","rdfs:label":"7","member":{"id":"https://genegraph.clinicalgenome.org/r/74b1a261-3bde-43c3-828b-9b4d4f694fb0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22961544","rdfs:label":"7:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/04523c24-eb2c-46bb-9f2c-8da510bb85cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.2789_2800del (p.Val930_Thr933del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190164"}},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/beb11041-1077-4cfb-9745-1b54cd734f17_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22961544","allele":{"id":"https://genegraph.clinicalgenome.org/r/04523c24-eb2c-46bb-9f2c-8da510bb85cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/74b1a261-3bde-43c3-828b-9b4d4f694fb0"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e1d38040-8b6d-47bc-a793-0163df585504_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","rdfs:label":"3","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/e1d38040-8b6d-47bc-a793-0163df585504","type":"Family","rdfs:label":"3","member":{"id":"https://genegraph.clinicalgenome.org/r/e1e831a4-5ae4-4404-b5c3-7b14f1eed5b3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","rdfs:label":"3:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/540e2759-d898-4650-a834-f2af6c7941db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e1e831a4-5ae4-4404-b5c3-7b14f1eed5b3"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/910f0091-e3c8-4c63-910b-67b7a0e223f7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36864778","rdfs:label":"12","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/910f0091-e3c8-4c63-910b-67b7a0e223f7","type":"Family","rdfs:label":"12","member":{"id":"https://genegraph.clinicalgenome.org/r/26e6459f-9f32-4b2d-bab8-8d41dbadad63","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36864778","rdfs:label":"12:1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":32,"allele":{"id":"https://genegraph.clinicalgenome.org/r/46bf91f7-269d-48b1-bc28-a4a1aed863e7"},"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d4a5e855-7745-4baa-947f-0be859521b14_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/26e6459f-9f32-4b2d-bab8-8d41dbadad63"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/5471c93e-5d09-4d20-b8b2-a2bd13216584_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22961544","rdfs:label":"5","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/5471c93e-5d09-4d20-b8b2-a2bd13216584","type":"Family","rdfs:label":"5","member":{"id":"https://genegraph.clinicalgenome.org/r/ece6bf27-6802-4358-a677-1f065dbeb2e7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22961544","rdfs:label":"5:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/26ff95f1-b763-4445-804e-86f50e83a535_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":12,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ece6bf27-6802-4358-a677-1f065dbeb2e7"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/49e1ed2a-30af-43be-acc9-165940437912_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27633507","rdfs:label":"9","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/49e1ed2a-30af-43be-acc9-165940437912","type":"Family","rdfs:label":"9","member":{"id":"https://genegraph.clinicalgenome.org/r/766c6cb3-f723-4a3b-9b86-41acef068752","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27633507","rdfs:label":"9:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/59a86e7e-7fc6-4c0d-a808-2e9ccba70f56"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/54650233-2a88-42cf-bd01-9944d31a8354_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":9,"proband":{"id":"https://genegraph.clinicalgenome.org/r/766c6cb3-f723-4a3b-9b86-41acef068752"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3544e379-313f-4303-a38e-1c03d9592951_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15929027","rdfs:label":"1","estimatedLodScore":4.82,"family":{"id":"https://genegraph.clinicalgenome.org/r/3544e379-313f-4303-a38e-1c03d9592951","type":"Family","rdfs:label":"1","member":{"id":"https://genegraph.clinicalgenome.org/r/1dfa884c-5c91-4d3c-bac1-1bffcff73eda","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15929027","rdfs:label":"1:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":60,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cfeab9dc-e990-4008-abc9-1ee9ab2e1df8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15929027","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0002515","obo:HP_0005110","obo:HP_0011712","obo:HP_0002093","obo:HP_0003236","obo:HP_0001324","obo:HP_0006785"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1dfa884c-5c91-4d3c-bac1-1bffcff73eda"},"publishedLodScore":4.879,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/644dc3ad-5e8c-4276-b3b8-78bcfe81d4e1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22961544","rdfs:label":"6","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/644dc3ad-5e8c-4276-b3b8-78bcfe81d4e1","type":"Family","rdfs:label":"6"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8bcd57d3-a2c0-4946-80fb-7ad897b7d695"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/431f9bff-a25d-43be-9a51-be54bb996f9f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","rdfs:label":"2","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/431f9bff-a25d-43be-9a51-be54bb996f9f","type":"Family","rdfs:label":"2","member":{"id":"https://genegraph.clinicalgenome.org/r/055474c5-cd7d-4e00-b3a7-3208550bc809","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","rdfs:label":"2:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6e63b831-285c-4bba-ad3d-7de136d8765f_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/055474c5-cd7d-4e00-b3a7-3208550bc809"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/24e4b7c9-9240-487b-a9ca-7322ad90558b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","rdfs:label":"4","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/24e4b7c9-9240-487b-a9ca-7322ad90558b","type":"Family","rdfs:label":"4","member":{"id":"https://genegraph.clinicalgenome.org/r/1c4aa540-a843-43a0-9f04-78ed8528f767","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","rdfs:label":"4:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6ef6de35-3a38-4fe1-9efd-90cd0007b776_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18055494","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa60916-78d3-4c16-9c54-2b150ceaf264"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/1c4aa540-a843-43a0-9f04-78ed8528f767"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cfeab9dc-e990-4008-abc9-1ee9ab2e1df8","type":"EvidenceLine","dc:description":"Seen in 6 families with 44 affected individuals ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfeab9dc-e990-4008-abc9-1ee9ab2e1df8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kley 2012 PMID:22961544 Transiently transferred C2 and C2C12 cells showed increased FLNC aggregation in cells expressing W2710* compared to WT ‚Äì up to 30x more  \nVorgerd 2005 PMID: 15929027 Patient muscle samples show FLNC aggregation by IMS & EM. Circular dichroism of W2710X showed improper folding compared to WT \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cfeab9dc-e990-4008-abc9-1ee9ab2e1df8_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/540e2759-d898-4650-a834-f2af6c7941db","type":"EvidenceLine","dc:description":"Variant already scored","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/540e2759-d898-4650-a834-f2af6c7941db_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kley 2012 PMID:22961544 Transiently transferred C2 and C2C12 cells showed increased FLNC aggregation in cells expressing W2710* compared to WT ‚Äì up to 30x more  \nVorgerd 2005 PMID: 15929027 Patient muscle samples show FLNC aggregation by IMS & EM. Circular dichroism of W2710X showed improper folding compared to WT \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/540e2759-d898-4650-a834-f2af6c7941db_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/762290d5-280c-4f2b-a347-39da696465fd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/762290d5-280c-4f2b-a347-39da696465fd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/6009f2df-d06a-4a8e-92ab-44d8d674252d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.6958G>A (p.Gly2320Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA166191873"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4916d07c-eb74-442d-8882-ecb6a18836bc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4916d07c-eb74-442d-8882-ecb6a18836bc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35952944","allele":{"id":"https://genegraph.clinicalgenome.org/r/52289ce8-0566-45e5-aaa4-316893b7c8a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.7529C>T (p.Ala2510Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369218851"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4c00ccd3-2a2a-4544-a121-ad82e3ccb7ee","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c00ccd3-2a2a-4544-a121-ad82e3ccb7ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30919686","allele":{"id":"https://genegraph.clinicalgenome.org/r/f242d1c0-8a4c-4f51-a8df-1cf4b145603e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001458.5(FLNC):c.6902C>T (p.Pro2301Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA369214126"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/beb11041-1077-4cfb-9745-1b54cd734f17","type":"EvidenceLine","dc:description":"Robust functional evidence ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/beb11041-1077-4cfb-9745-1b54cd734f17_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Shatunov et al., 2009 (19050726)\nThe 12-bp deletion was shown to be inframe, removal of 4 AAs. Western blot of patient muscle tissue showed expression of FLNC mutant protein\nPt muscle biopsy showed aggregation of FLNC, along with DES, ubiquitin, myotilin, and dystrophin aggregation \nKley et al., 2012 (22961544)\nCircular dichrioism showed thermostability changes in the mutant construct and protease digestion showed enhanced degredation compared to WT\nIncreased FLNC aggregation compared to WT \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/beb11041-1077-4cfb-9745-1b54cd734f17_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6ef6de35-3a38-4fe1-9efd-90cd0007b776","type":"EvidenceLine","dc:description":"Variant already scored ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ef6de35-3a38-4fe1-9efd-90cd0007b776_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kley 2012 PMID:22961544 Transiently transferred C2 and C2C12 cells showed increased FLNC aggregation in cells expressing W2710* compared to WT ‚Äì up to 30x more  \nVorgerd 2005 PMID: 15929027 Patient muscle samples show FLNC aggregation by IMS & EM. Circular dichroism of W2710X showed improper folding compared to WT \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6ef6de35-3a38-4fe1-9efd-90cd0007b776_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.3},{"id":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da87e08d-e9e1-44a6-9b5a-62070c639764","type":"EvidenceLine","dc:description":"Zebrafish Model ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1f32fc2-1fa7-46a0-803c-ffdf26f7436e","type":"Finding","dc:description":"FLNCW2710X causes protein aggregation \nFLNC is a target of the BAG3-mediated chaperone assisted selective autophagy (CASA) pathway and similar to those found in patients, the aggregates in FLNCW2710X expressing fish contain the co-chaperone BAG3. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26969713","rdfs:label":"Ruparelia Zebrafish Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d64c18af-7289-4057-ab54-d131f290f3dd","type":"EvidenceLine","dc:description":"Zebra fish model ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ece6d5e9-601c-4caa-837c-4afc50182237","type":"Finding","dc:description":"Overexpression of eGFP-labled FLNC (p.A1183L & p.A1186V) in zebra fish embryos causes formation of protein aggregates and mild Z-disc abnormalities seen by confocal imaging \nSkeletal muscle aggregates 4E & 4F\nZ-disc streaming along myofibrils in 4H\nAbnormal Z-disc patterning 4I\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29858533","rdfs:label":"Kiselev Zebra Fish model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6108e2af-80ca-4482-92e7-ce73c42eb046","type":"EvidenceLine","dc:description":"Showed phenotype in mice over time ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4eb2dd3d-e7bb-496c-a636-f8fb284ccd25","type":"Finding","dc:description":"Transgenic ice were develoepd using a gene-trap technology to replace the TGG codon in mouse 2711 (equivalent to human 2710) with TGA, and creating the hW2710/ m2711* patient derived variant. \nThe W2711 het mice were studied. No significant change in body weight was observed from 2-12 months (checking every 2 months). \nThe W2711 mice showed reduced ability to hang from a wire at all time points, with significance reached at 10 and 12 months ( Figure 3 B). \nFurthemore, the mice showed redued gripstrength for 4 paws at 4 months (significant) and trended all others. For the forelimb grip strength the W2711* mutant mice showed reduced strength at 4 and 8 months (statistically significant). \nEM of the soleus muscle of the W2711* mice showed aggregation and disorganization of myofibrils. BY IMS of soleus muscle, aggregation of the mutant FLNC was observed, as well as accumulation/ aggregation of XIn, and DES, consistent with pathology obesrved in humans (Figure 5). \nIncreases in micro- and macro-lesions were observed in the non-exercised and exercised mice (Figure 6), as well as sarcomeric lesions. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26472074","rdfs:label":"FLNC mouse model - Myofibrillar instability & acute exercise","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/230ea8a8-3315-422c-842e-a7ceeaa093ea","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3fab3ba-ea1a-4845-b57d-63b96d1e12f6","type":"Finding","dc:description":"Compared to WT FLNC+/‚àÜ7aa :\nDid not effect FLNC expression \nDid not effect sarcomere formation and function\nCaused aggregate formation\nCaused increases in lysosome content, enhancement of autoflux, and accumulation of FLNC-binding partners & Z-disc proteins \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34405687","rdfs:label":"Agarwal cell culture model ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/d61672a0-06f2-4df4-845b-57566075fdb1_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/850c0380-b37f-40f3-828b-87503beb832d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bbaefb1-06ef-4948-8f99-928195964c24","type":"Finding","dc:description":"Gontier 2005, Faulkner 2000, Frey 2002, Holmes 2008, Linnemann 2010, Lu 2003, Takada 2001, Thompson 2000, van der Ven 2000","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23109048","rdfs:label":"Furst biochemical function","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/db966199-e98c-42fa-965a-df05f7f2690d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49cbe92a-7b82-438e-8b6a-540fc9b87349","type":"Finding","dc:description":"Y2H showed that the titin domain Z2-Zis1 interacts with FLNC\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16949617","rdfs:label":"Labeit protein interaction","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e552dd99-8f97-4e43-9d5a-7be86aaae978","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28b20766-53fd-43fb-a6ee-1c7a2838a96e","type":"Finding","dc:description":"Y2H method showed 2 Ig-like domains from myotilin interacted directly with Ig-like domain 20 of FLNC ‚Äì indicating that the amino-terminal of FLNC may be indirectly anchored to ùõº-actinin in the Z-disc via myotilin\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11038172","rdfs:label":"Van der Ven protein interaction","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0234ae2a-87c4-4bda-a292-87e503a1ec3e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17efe485-d0c4-4783-a6e1-3d8bf27c02af","type":"Finding","dc:description":"Rt-PCR of human mRNA samples showed expression of FLNC in the heart and skeletal muscle \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9791010","rdfs:label":"Xie Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":8691,"specifiedBy":"GeneValidityCriteria9","strengthScore":13.3,"subject":{"id":"https://genegraph.clinicalgenome.org/r/P9KB7N2cZDg","type":"GeneValidityProposition","disease":"obo:MONDO_0018943","gene":"hgnc:3756","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d61672a0-06f2-4df4-845b-57566075fdb1-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}